Shineco, INC

Market Movers (8-K)

OTC.Pink
Shineco, Inc. has been delisted from The Nasdaq Stock Market LLC due to non-compliance with the minimum bid price requirement, effective October 7, 2025.
Delay expected
Worse than expected
OTC.Pink
Shineco Inc. faces potential delisting from Nasdaq due to non-compliance with the minimum bid price rule, though a review council has temporarily stayed the suspension while a lawsuit against Nasdaq remains pending.
Worse than expected
Delay expected
OTC.Pink
Shineco, Inc. announced the completion of an unregistered offering, issuing 18 million common shares to non-U.S. investors for gross proceeds of $13.5 million.
Capital raise
OTC.Pink
Shineco, Inc. has filed an amended 8-K to provide the required financial statements for its recently acquired 51% equity interest in InfiniClone Limited, an iPSC technology company, detailing the acquisition's financial impact and InfiniClone's historical performance.
Capital raise
Worse than expected
OTC.Pink
Shineco, Inc.'s subsidiary, Shineco Life Science Group Hong Kong Co., Limited, has completed the acquisition of a 51% equity interest in InfiniClone Limited for $19.9 million in cash and 3.45 million shares of common stock.
OTC.Pink
Shineco, Inc. has received a Nasdaq staff determination letter indicating non-compliance with the minimum bid price requirement, leading to an impending trading suspension unless an appeal is successfully lodged.
Worse than expected

Quarterly Earnings (10-Q)

OTC.Pink
Shineco, Inc. reports a net loss of $21.46 million for the nine months ended March 31, 2025, driven by losses from discontinued operations.
Worse than expected
Capital raise
OTC.Pink
Shineco Inc.'s Q2 2025 results show increased revenue but continued net losses, alongside a reverse stock split and ongoing efforts to address internal control weaknesses.
Capital raise
Worse than expected
OTC.Pink
Shineco Inc. reports a net loss for the quarter ended September 30, 2024, while navigating business segment changes and raising capital through multiple offerings.
Worse than expected
Capital raise
OTC.Pink
Shineco Inc. experienced significant revenue growth in the third quarter of 2024, primarily driven by recent acquisitions, but also saw a substantial increase in net losses due to higher operating expenses.
Worse than expected
Capital raise
OTC.Pink
Shineco Inc. reports a net income of $286,021 for the six months ended December 31, 2023, driven by gains from discontinued operations, while facing challenges in its continuing operations.
Worse than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Shineco, Inc. has agreed with Streeterville Capital, LLC to extend the maturity date of a convertible promissory note, adding a 4% extension fee to the outstanding balance.
Delay expected
Capital raise
Worse than expected

Proxy Statements (Def-14A)

OTC.Pink
A majority of voting stockholders approved a reverse stock split for a company to meet Nasdaq's minimum bid price requirements, with the exact ratio to be determined by the Board.
Worse than expected
OTC.Pink
Shineco, Inc. is asking stockholders to approve a reverse stock split and a new equity incentive plan at its upcoming annual meeting.
Worse than expected

New Public Companies (S-1)

OTC.Pink
Shineco, a Delaware-based holding company with operations in China, is registering for the resale of up to 15 million shares of its common stock by selling stockholders, amidst ongoing regulatory uncertainties in China.
Worse than expected
OTC.Pink
Shineco, Inc. has filed a registration statement for the resale of up to 15,000,000 shares of its common stock by selling stockholders.

Schedule 13D - Activist Investments

OTC.Pink
Shanchun Huang, an individual investor and affiliate, has significantly increased his beneficial ownership in Shineco, Inc. to 29.4% through recent share acquisitions totaling $15.9 million, signaling an active investment strategy.
Capital raise